ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 927,62
0,00%
Dow Jones
44 424,25
-0,32%
DAX
21 394,93
-0,11%
Brent Oil
76,935
-0,32%
Bitcoin
100 428,78
-2,18%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Canadá
  5. TSXV

  6. Theralase Technologies Inc (TLT) Cours

Theralase Technologies Inc

Theralase Technologies Inc (TLT)

Tilt Renewables Limited
The London Tunnels PLC
iShares 20+ Year Treasury Bond ETF
iShares 20 plus Year Treasury Bond
0,25
-0,02
(-7,41%)
Fermé 27 Janvier 10:00PM
Retardé de 15 minutes

Donnez du pouvoir à votre portefeuille : discussions en temps réel et idées de trading exploitables.

Premium

Statistiques et détails clés

Dernier
0,25
Prix Achat
0,255
Prix Vente
0,26
Volume échangé
124 200
0,25 Fourchette du Jour 0,26
0,00 Plage de 52 semaines 0,00
Cap du marché
57,115M
Clôture Veille
0,27
Ouverture
0,26
Dernière Transaction
21500
@
0.25
Dernière heure de transaction
Volume financier
-
VWAP
-
Volume moyen (3 m)
-
Actions en circulation
228 460 000
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-12,50
Bénéfice par action (BPA)
-0,02
Chiffre d'affairess
1,07M
Bénéfice net
-4,57M

À propos de Theralase Technologies Inc

Secteur
Electromedical Apparatus
Industrie
Electromedical Apparatus
Site Web
www.theralase.com
Siège social
Toronto, Ontario, Can
Fondé
-
Theralase Technologies Inc est coté dans le secteur Electromedical Apparatus de la TSX Venture Exchange avec le ticker TLT. Le dernier cours de clôture d'Theralase Technologies était de $0,27. Au cours de la dernière année, les actions de Theralase Technologies ont été négociées dans une fourchette de prix de $ 0,00 à $ 0,00.

Theralase Technologies compte actuellement 228 460 000 actions en circulation. La capitalisation boursière d'Theralase Technologies est de $61,68 million. Theralase Technologies a un ratio cours/bénéfice (ratio PE) de -12.50.

TLT Dernières nouvelles

Plus de nouvelles

Theralase® Releases FY2022 Audited Financial Statements

TORONTO, April 26, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the...

27 Avril 2023
GlobeNewswire Inc.

Theralase® Phase II NMIBC Clinical Study (Interim) Data Presented at the ASCO GU Cancer Symposium

TORONTO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

23 Février 2023
GlobeNewswire Inc.

Theralase® Awarded TSX Venture 50™ Recognition as a Top Performing Company

TORONTO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

21 Février 2023
GlobeNewswire Inc.

Theralase® Phase II NMIBC Clinical Study (Interim) Data to be Presented at the AUA Annual Meeting

TORONTO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

02 Février 2023
GlobeNewswire Inc.

Theralase® Phase II NMIBC Clinical Study (Interim) Data to be Presented at the ASCO GU Cancer Symposium

TORONTO, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

25 Janvier 2023
GlobeNewswire Inc.

Theralase ® Announces Warrant Extension

TORONTO, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or “Company”) (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and...

06 Janvier 2023
GlobeNewswire Inc.

Theralase Releases Q322 Interim Financial Statements

TORONTO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the...

30 Novembre 2022
GlobeNewswire Inc.

Theralase® Grants Stock Options

TORONTO, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

21 Novembre 2022
GlobeNewswire Inc.

Theralase ® Closes Private Placement Equity Financing

TORONTO, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company focused on the...

17 Novembre 2022
GlobeNewswire Inc.

Theralase® Commences $CAN 2.5 M Follow-On Private Placement Equity Financing

Not for distribution to U.S. news wire services or dissemination in the United States. TORONTO, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase®” or the “Company”...

03 Octobre 2022
GlobeNewswire Inc.
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

TLT - Frequently Asked Questions (FAQ)

What is the current Theralase Technologies share price?
The current share price of Theralase Technologies is $ 0,25
How many Theralase Technologies shares are in issue?
Theralase Technologies has 228 460 000 shares in issue
What is the market cap of Theralase Technologies?
The market capitalisation of Theralase Technologies is CAD 61,68M
What is the 1 year trading range for Theralase Technologies share price?
Theralase Technologies has traded in the range of $ 0,00 to $ 0,00 during the past year
What is the PE ratio of Theralase Technologies?
The price to earnings ratio of Theralase Technologies is -12,5
What is the cash to sales ratio of Theralase Technologies?
The cash to sales ratio of Theralase Technologies is 53,19
What is the reporting currency for Theralase Technologies?
Theralase Technologies reports financial results in CAD
What is the latest annual turnover for Theralase Technologies?
The latest annual turnover of Theralase Technologies is CAD 1,07M
What is the latest annual profit for Theralase Technologies?
The latest annual profit of Theralase Technologies is CAD -4,57M
What is the registered address of Theralase Technologies?
The registered address for Theralase Technologies is 41 HOLLINGER ROAD, TORONTO, ONTARIO, M4B 3G4
What is the Theralase Technologies website address?
The website address for Theralase Technologies is www.theralase.com
Which industry sector does Theralase Technologies operate in?
Theralase Technologies operates in the ELECTROMEDICAL APPARATUS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
ADEAdex Mining Inc
$ 0,01
(100,00%)
1 000
DEALPlaygon Games Inc
$ 0,02
(100,00%)
1,75M
TVC.HThree Valley Copper Corp
$ 0,01
(100,00%)
15,6k
GBUGabriel Resources Ltd
$ 0,01
(100,00%)
167k
MACThemac Resources Group Ltd
$ 0,08
(60,00%)
3k
NAVNAVCO Pharmaceuticals Inc
$ 0,005
(-50,00%)
16,63k
SMAR.PSmartset Services Inc
$ 0,015
(-50,00%)
30k
ETUE2gold Inc
$ 0,005
(-50,00%)
101,7k
DDDMetavista3D Inc
$ 2,30
(-49,45%)
701,59k
MXL.HMX Gold Corp
$ 0,04
(-46,67%)
1,5k
NDANeptune Digital Assets Corp
$ 2,20
(30,18%)
5,15M
BRCBlackrock Silver Corp
$ 0,355
(-11,25%)
3,79M
TDGTDG Gold Corp
$ 0,45
(-1,10%)
3,19M
GPUSAlset AI Ventures Inc
$ 0,14
(-12,50%)
2,79M
PNGKraken Robotics Inc
$ 2,87
(0,35%)
2,69M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

TSXV
TLT
Theralase Technologies
BIT
UC4VEZ
Unicredit Bank
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés